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Randomized clinical trial to evaluate the
pathogenicity of Bibersteinia trehalosi in
respiratory disease among calves
Christy J Hanthorn1, Reneé D Dewell1,2, Vickie L Cooper1, Timothy S Frana1, Paul J Plummer1,3, Chong Wang1,4
and Grant A Dewell1*
Abstract
Background: Bibersteinia trehalosi causes respiratory disease in ruminants particularly in wild and domestic sheep.
Recently, there has been an increased number of B. trehalosi isolates obtained from diagnostic samples from bovine
respiratory disease cases. This study evaluated the role of B. trehalosi in bovine respiratory disease using an intra-tracheal
inoculation model in calves. Thirty six cross bred 2–3 month old dairy calves were inoculated intra-tracheally with
either leukotoxin negative B. trehalosi, leukotoxin positive B. trehalosi isolate, Mannheimia haemolytica, a combination of
leukotoxin negative B. trehalosi and M. haemolytica or negative control. Calves were euthanized and necropsy
performed on day 10 of study.
Results: B. trehalosi inoculated calves did not have increased lung involvement compared to control calves.
Additionally, B. trehalosi was only cultured once from the lungs of inoculated calves at necropsy.
Conclusions: Based on these findings B. trehalosi may not be a primary pathogen of respiratory disease in cattle.
Culture of B. trehalosi from diagnostic submissions should not be immediately identified as a primary cause of
respiratory disease.
Keywords: Bibersteinia trehalosi, Bovine respiratory disease, Calf, Pneumonia, Pasteurellosis
Background
Bibersteinia trehalosi is a known pathogen of ruminants
and has been identified worldwide [1]. B. trehalosi was
formerly included in a single species of Pasteurella haemo-
lytica as biotype T [2]. This pathogen was recently reclassi-
fied as B. trehalosi on the basis of phylogenetic studies [3].
B. trehalosi has been associated with systemic pasteurel-
losis or septicaemia in lambs [4] and pneumonia in big-
horn sheep (Ovis canadensis) [5,6].
Although B. trehalosi infections are considered rare in
cattle, the agent is occasionally isolated from bovine lungs.
Diagnostic reports of severe non-responsive Bovine Re-
spiratory Disease (BRD) outbreaks associated with multi-
drug resistant B. trehalosi have been documented [7].
Clinical manifestations of these strains are often associated
with multi-drug resistance and severe lung pathology. The
reasons for development of these potentially highly viru-
lent strains remain unclear. It has been hypothesized that
B. trehalosi may have acquired increased pathogenicity
from other bacteria. Some reports in the literature suggest
that B. trehalosi and Mannheimia haemolytica can share
genetic material [8,9]. Earlier work has shown that nucleo-
tide diversity of lktA from B. trehalosi is minimal (0.7%)
compared to M. haemolytica (22.0%) and were genetically
different from M. haemolytica [10]. However, this report
included only B. trehalosi isolates from ovine samples.
Bovine adapted isolates of B. trehalosi may have acquired
some genetic material from M. heamolytica increasing its
ability to infect cattle.
Understanding the role different pathogens play in
BRD is critical to understanding and effectively treating
clinical cases. The primary objective of this study was to
evaluate the pathogenicity of B. trehalosi in respiratory
disease among calves using field strains of B. trehalosi.
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Methods
Two B. trehalosi isolates were identified from diagnostic
submissions of bovine cases for the challenge study. Iso-
late identification was confirmed by 16S ribosomal RNA
analysis. One isolate was PCR positive for the leukotoxin
(lktA) gene [11] and the other isolate was negative. The
lktA gene was amplified with a 5′ primer lktA9 (5′-TC
AAGAAGAGCTGGCAAC-3′) and the 3′ primer lktA7
(5′-AGTGAGGGCAACTAAACC-3′). Amplification pa-
rameters were: denaturation at 94°C for 45 s, annealing
at 62°C for 45 s, and extension at 72 C for 2 min. The
leukotoxin-PCR-positive B. trehalosi isolate was cultured
from the lungs, along with a Pasteurella multocida, from
a feedlot calf that had been treated with antibiotics mul-
tiple times for Bovine Respiratory Disease that had fibri-
nosuppurative bronchopneumonia from a group of 273 kg
Southeastern feedlot calves with 16% respiratory mor-
bidity and 10% mortality. The leukotoxin-PCR-negative
B. trehalosi isolate was cultured from the brain of a bull
with multifocal, suppurative meningoencephalitis.
Thirty six 8–12 week old individually housed Holstein
cross steer calves were obtained from a private calf raiser.
Calves were tested for persistent infection by BVDV by
immunohistochemistry prior to purchase and confirmed
PI negative. Nasal swab samples were collected from each
calf and submitted for bacterial culture to the diagnostic
lab prior (Day −1) to inoculation. During the experimental
challenge, calves were housed in a Biosecurity Level 2
facility at the ISU Livestock Infectious Disease Isolation
Facility. Each calf was confined separately in raised 0.9 ×
1.8 meter pens that provided no opportunity for calf-to-
calf contact in a room that held 12 calves at a time. Three
groups of calves were utilized to accommodate room lay-
out. Calves were provided free choice water and were fed
mixed grass hay and a pre-mixed calf starter. Biosecurity
procedures such as changing protective gloves and clothing
between calves were employed by all research personnel
working with calves. Calves were randomly assigned by a
random number generator [12] to one of five treatments.
Treatments were randomly assigned to 1 of 3 replicates
(Table 1). Eight calves were assigned to each bacterial
challenge treatment and 4 calves to a negative control
treatment.
The 5 treatment groups were:
1) Negative control (Brain Heart Infusion broth),
2) Leukotoxin negative B. trehalosi,
3) Leukotoxin positive B. trehalosi,
4) M. haemolytica
5) Combination of leukotoxin negative B. trehalosi and
M. haemolytica
Prior to inoculation, each isolate was grown overnight
on two blood agar plates and then transferred to a Brain
Heart Infusion broth immediately prior to inoculation to
obtain an estimated 2.5 × 109 CFU of bacteria per ml.
Isolates for group 5 had an estimated 2.5 × 109 CFU of
bacteria per ml for both leukotoxin negative B. trehalosi
and M. haemolytica for a total of 5 × 109 CFU of bacteria
per ml. A small sample of the inoculum was enumerated
on blood agar plates to determine exact concentration of
the inoculum. Inoculums ranged on average from 1.7 ×
109 to 3.3 × 109 CFU of bacteria per ml of broth. A sterile
90 cm number 8 French Foley catheter (MILA Inter-
national) was used to inoculate each calf. The researcher
administering the inoculum was masked to the treatment
being administered. For each inoculation, a sterile catheter
was passed intranasal to approximately the bifurcation
of the trachea and 20 ml of the inoculum was infused.
Following inoculation, the calf ’s head was briefly elevated.
Following inoculation, calves were monitored twice daily
by trained personnel masked to treatment on Days 0–9.
Measurements recorded included rectal temperature,
pulse rate and respiration rate. In addition each calf
was clinically assessed and assigned a respiratory and
depression score during twice daily monitoring. The
following scoring systems were used for the study.
Respiratory scores:
0 – Normal, eyes are clear, nose is clean with no
discharge, normal breathing
1 – Mild Respiratory, serous discharge from eyes and\or
nose, slight cough
2 – Moderate Respiratory, muco-purulent discharge,
cough, increased respiratory rate
3 – Severe Respiratory, excessive muco-purulent
discharge, harsh cough, open mouth breathing
Depression scores
0 – Normal, cattle are bright and alert, hold their
head up and readily move away from the observer
1 – Mild depression, cattle’s attitude is slightly
depressed but respond quickly to observer and
appear normal
Table 1 Replicate and treatment group assignments
Replicate 1 Replicate 2 Replicate 3
Control Calves 1 1 2
Leukotoxin negative
B. trehalosi
3 3 2
Leukotoxin postive
B. trehalosi
3 3 2
M. haemolytica 3 2 3
M. haemolytica and
leukotoxin negative B. trehalosi
2 3 3
Assignment of calves to treatment groups by replicate of study presented in
table format.
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2 – Moderate depression, cattle stand with head
down, ears droop, abdomen lack of fill and may
appear floppy, cattle move away slowly from
observer
3 – Severe depression, cattle stand with head down
and very reluctant to move, very noticeable
gauntness of abdomen
Any calf that was assigned a respiratory and/or depres-
sion score of three was considered a candidate for euthan-
asia. If calf was determined to be moribund from physical
exam, it was humanly euthanized. All surviving calves
were euthanized on day 9 of the study by use of captive
bolt followed by pithing. All euthanasias followed American
Veterinary Medical Association guidelines [13].
Immediately following euthanasia, a necropsy was
performed on each calf. The respiratory system was
evaluated by a diagnostic pathologist. The percent ab-
normal lung was visually estimated for each lobe and
total lung involvement calculated as a percentage of
total lung as described by Jericho and Langford [14].
Samples of representative lung as determined by the
pathologist were submitted ISU Veterinary Diagnostic
Laboratory for routine culture and histology. For culture,
samples were plated on bovine blood agar and incubated
aerobically at 35°C, sheep blood agar and incubated anaer-
obically at 35°C and tergitol-7 agar and incubated aerobic-
ally at 35°C. All samples were incubated overnight and
suspect hemolytic and non-hemolytic colonies were se-
lected for identification by matrix-assisted laser desorp-
tion/ionization–time of flight (MALDI-TOF).
This protocol was approved by the Iowa State University
Institutional Animal Care and Use Committee (#5-12-
7352-B) and the Institutional Biosafety Committee
(#12-I-0017-A). Personnel conducting daily monitor-
ing, the pathologist and the statistician were blinded to
calves treatment group.
Statistical analysis
Our goal was to describe the magnitude and variation of
our collected measurements and assess the association of
these variables with BRD and B. trehalosi. The primary
outcome of interest included percent lung involvement,
temperature, depression score and respiratory score. The
percent abnormal lung response was analyzed using
mixed effect Analysis of Variance (ANOVA) model, with
Treatment as fixed effect and Group as a random effect.
The remaining responses (Temperature, Depression score,
and Respiratory score) were analyzed using repeated
measures ANOVA model, with Treatment, time and
their interaction as fixed effects and group as random
effect. Comparisons among treatment groups were per-
formed using Tukey’s t-tests. SAS® Version 9.2 (SAS®
Institute Inc., Cary, NC, USA) was used in analyses. A
p-value <0.05 was considered significant.
Results
Thirty five of the thirty six candidates were enrolled in the
study. One calf assigned to the M. haemolytica group died
prior to enrollment in study. Pasturella multocida was
isolated from nasal swab samples from 34 of 35 calves. M.
haemolytica was isolated from 8 of 35 calves. M. haemoly-
tica positive nasal swab calves were fairly evenly spread
across all five treatment groups (1/4 in Control group, 1/8
in Leukotoxin negative B. trehalosi group, 2/8 Leukotoxin
positive B. trehalosi group, 1/7M. haemolytica group, 3/8
leukotoxin negative B. trehalosi and M. haemolytica com-
bination group). Six of the 35 enrolled calves were eutha-
nized prior to day 9 of the study. Three of the euthanized
calves (3/7) in M. haemolytica group (days 1, 2 and 2) and
three calves (3/8) from the leukotoxin negative B. trehalosi
and M. haemolytica combination treatment (days 2, 4 and
7) were euthanized according to protocol because of a
clinical assessment of moribund. Overall, the mean esti-
mated percent lung involvement was highest for the M.
haemolytica group (49%) followed by the mixed infection
of M. haemolytica and leukotoxin negative B. trehalosi
(26%). The leukotoxin postive B. trehalosi had a mean
18% estimated lung involvement while the leukotoxin
negative B. trehalosi mean lung involvement was esti-
mated to be 13%. The control group had a mean lung in-
volvement estimate of 13% (Table 2). Calves with lung
involvement had histologic lesions that were consistent
with bronchointerstitial pneumonia (26 of 35 calves) and
20 of these calves also had evidence of pyogranulomatus
pneumonia.
M. haemolytica was isolated from5 of 7 lungs of the
M. haemolytica inoculated group and 4 of 8 lungs from
the leukotoxin negative B. trehalosi and M. haemolytica
combination group. B. trehalosi was isolated from one of
24 lungs that were inoculated with B. trehalosi. Calf
number 6 in the leukotoxin negative B. trehalosi and M.
haemolytica combination inoculation treatment group
was euthanized on day 2 of the study as reported above.
The calf had 71.6% lung involvement and both M. hae-
molytica and a B. trehalosi were isolated from the lung
tissue. B. trehalosi was not isolated from the lung tissue
of any other calves that were inoculated with a B. treha-
losi isolate.
Rectal temperature (Figure 1), depression scores (Figure 2)
and respiratory scores (Figure 3) followed an expected
pattern after inoculation. Overall, rectal temperatures
ranged from 35.3-41.3°C. Depression scores ranged
from 0–3 and respiratory scores ranged from 0–3.There
were occasional time periods when differences in rectal
temperatures, depression score or respiratory score
between the M. haemolytica and the B. trehalosi or
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Table 2 Percent lung involvement by treatment group
Control Leukotoxin negative
B. trehalosi
Leukotoxin postive
B. trehalosi
M. haemolytica M. haemolytica and leukotoxin
negative B. trehalosi
Calves 20.4 0 36.55 57.25 71.6
26.2 24.25 27.1 53.95 61.3
0 21.7 28.1 26 62.85
4.4 32.1 27.1 33.15 0
18.05 14.2 28.6 1.8
6.15 1.5 63.6 0.6
3.6 11.35 75.1 4.75
0 1.45 6.1
Mean* 12.75 a 13.2 a 18.4 a 48.2 b 26.1 a, b
Adj P value** 0.9999 0.9981 0.0715 0.8049
*means with different letters are statistically different (p < 0.05).
**Adj p value of treatment from the control group.
Individual and mean lung involved in disease process as a percentage of total lung volume. Treatment group means that were statistically different from other
treatment groups are indicated by different letters (a or b) in table. Adjusted p-values of treatment group from control group is reported.
38.5
38.7
38.9
39.1
39.3
39.5
39.7
39.9
40.1
40.3
40.5
Control
Leukotoxin negative B. trehalosi
Leukotoxin postive B. trehalosi
M. haemolytica
M. haemolytica and leukotoxin negative B. trehalosi
a
b
Figure 1 Temperature over time by treatment group. Line graph of rectal temperature by treatment group for each time point when
temperature was recorded. Time points that were statistically different are indicated by different letters (a or b).
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control groups were statistically significant (Figures 1,
2 and 3).
The calves from both groups inoculated with B. treha-
losi demonstrated increased rectal temperature (>39.5°C)
at 7 hours after inoculation compared to calves that had
been inoculated with M. haemolytica. Temperatures for
the two B. trehalosi only treatment groups returned to
normal levels (37.5 – 39.5°C) within 12 hours. Calves in
the M. haemolytica only inoculation group did not dem-
onstrate increased rectal temperatures (>39.5°C) on aver-
age until 24 hours following inoculation and temperatures
of these calves remained elevated except for morning
0
0.5
1
1.5
2
2.5
Day
1 Pre
Day
1 4
hrs
post
Day
2 AM
Day
2 PM
Day
3 AM
Day
3 PM
Day
4 AM
Day
4 PM
Day
5 AM
Day
5 PM
Day
6 AM
Day
6 PM
Day
7 AM
Day
7 PM
Day
8 AM
Day
8 PM
Day
9 AM
Day
9 PM
Day
10
AM
Control
Leukotoxin negative B. trehalosi
Leukotoxin postive B. trehalosi
M. haemolytica
M. haemolytica and leukotoxin negative B. trehalosi
a
b
a
b
a
b
a
b
a
b
aaa
b
b
b
Figure 2 Depression score over time by Treatment group. Line graph of depression score by treatment group for each time point when
depression score was recorded. Time points that were statistically different are indicated by different letters (a or b).
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Day
1 Pre
Day
1 4
hrs
post
Day
2 AM
Day
2 PM
Day
3 AM
Day
3 PM
Day
4 AM
Day
4 PM
Day
5 AM
Day
5 PM
Day
6 AM
Day
6 PM
Day
7 AM
Day
7 PM
Day
8 AM
Day
8 PM
Day
9 AM
Day
9 PM
Day
10
AM
Control
Leukotoxin negative B. trehalosi
Leukotoxin postive B. trehalosi
M. haemolytica
M. haemolytica and leukotoxin negative B. trehalosi
a
b
a
b
Figure 3 Respiratory score over time by treatment group. Line graph of respiratory score by treatment group for each time point when
respiratory score was recorded. Time points that were statistically different are indicated by different letters (a or b).
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of day 2. Calves in the combined inoculation group
fluctuated above and below 39.5°C throughout the study
(Figure 1).
Depression scores (Figure 2) for the M. haemolytica
inoculation group began to increase 4 hours post inocu-
lation and remained elevated at 1 or greater throughout
the study. The combined inoculation group did not have
increased depression scores (≥1) until Day 3 of the study
and never reached the severity of the M. haemolytica
only inoculation group. Neither of the B. trehalosi inocula-
tion groups had elevated depression scores. The average
depression score for the control group was 0.2. Both B.
trehalosi only inoculation groups had an average depres-
sion score of 0.3 while the M. haemolytica inoculation
group had an average of 1.3. The combined inoculation
group had an average depression score of 0.6.Respiratory
scores for the M. haemolytica inoculation group ranged
from 0–3 and were not consistently abnormal (≥1) until
Day 3 of the study. None of the other groups had elevated
average respiratory scores (Table 3).
Discussion
Results of this study indicate that B. trehalosi isolates
used in this study are not associated with significant dis-
ease in a research setting. Calves inoculated with either
a leukotoxin positive (PCR positive for the leukotoxin
(lktA) gene ) or leukotoxin negative isolate of B. trehalosi
did not demonstrate increased lung involvement com-
pared to control calves. This finding contradicts some
perceptions that B. trehalosi is an emerging primary re-
spiratory pathogen of cattle [7]. In contrast, this study’s
results are more supportive of B. trehalosi’s role in BRD
as secondary and perhaps opportunistic bacteria. Re-
ports of B. trehalosi associated pneumonia are from
diagnostic submissions, often without access to history
of inciting causes of respiratory disease, nutritional
health of calves, additional stressors or information on
antimicrobial therapies. In this challenge model healthy
calves were challenged with field isolates of B. trehalosi
and extensive lung involvement was not identified post
inoculation.
The limitations of this study include the small size of
the study, isolate credibility, the inoculation method and
the health status of the calves prior to inoculation. The
study was designed as a pilot study to evaluate the patho-
genicity of B. trehalosi in cattle. The number of calves in
each group was limited as much as possible to decrease
the number of calves sacrificed while still providing im-
portant information. The small size of the study decreases
the statistical power to identify statically significant differ-
ences even though numerically the difference between
the negative control group (inoculated with broth only)
and the positive control group (M. haemolytica) were
substantial.
The authors are unaware of any B. trehalosi isolates
that have demonstrated pathogenicity in a challenge
model in cattle. The B. trehalosi isolates selected for this
study originated from field submissions to a diagnostic
laboratory. Our approach was to use leukotoxin positive
and negative B. trehalosi isolates that had been associ-
ated with respiratory disease and could potentially be
associated with lung pathology in the study calves.
Though unlikely, it is possible that, during the inocula-
tion procedure, the dose was inadvertently misplaced
into the esophagus instead of the lungs. There are multiple
bovine respiratory disease challenge models cited in the
literature including trans-tracheal injection, trans-thoracic
injection, bronchoscope and using a nasal-tracheal ap-
proach that this study utilized. Confirmation that the cath-
eter was correctly placed in the trachea as opposed to the
esophagus can be difficult. However, the M. haemolytica
positive control group, had substantial lung involvement
and a p-value of 0.07 compared to the negative control
group suggesting that the inoculation technique and the
challenge model was valid.
Calves in the study were conventionally reared dairy
crossbred calves. Calves were purchased from a calf raiser
and were considered clinically normal at the time of pur-
chase and did not exhibit signs of respiratory disease at
enrollment. However, two calves in the control group had
lung lesions (20–26% lung involvement). Thus, this path-
ology was presumed to have resulted from a previous in-
fection not associated with inoculation. Evidence of lung
pathology from prior respiratory disease in some control
calves may confound results between treatment groups.
Histologic lesions characteristic of a previous BRSV infec-
tion was seen in 17 of the calves. Since two control calves
demonstrated some lung pathology, the potential differ-
ence between treatment groups and the control group was
affected.
Pre-study pharyngeal swabs did not identify any calves
carrying B. trehalosi and the calf farm did not have a
Table 3 Average depression and respiratory score by
treatment group
Average peak
depression score
(Range)
Average peak
respiratory score
(Range)
Control 0.25 (0–1) 1 (1–1)
Leukotoxin negative
B. trehalosi
0.75 (0–2) 1 (0–1)
Leukotoxin postive
B. trehalosi
1 (0–2) 1.25 (1–2)
M. haemolytica 2 (0–3) 1.7 (1–3)
M. haemolytica and
leukotoxin negative
B. trehalosi
1.25 (0–3) 1.25 (0–3)
Average depression and respiratory scores over the course of the study are
reported for each treatment group in table format.
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history of B. trehalosi disease. Despite this, it is still pos-
sible that calves could have had exposure to B. trehalosi
prior to enrollment in the project. Given the age of the
calves, it is also possible that passive immunity played a
role in immune response. However, there is currently not
a validated serologic test for cattle to determine previous
exposure to B. trehalosi. Therefore, it is possible that
calves may have had previous unknown exposure to B. tre-
halosi that enhanced their immunological response.
It was surprising that calves inoculated with a combin-
ation of M. haemolytica and B. trehalosi tended to have
numerically less lung involvement than that of M. haemo-
lytica inoculation alone (difference was not significant).
One would expect that mixed infections would potentiate
increased lung involvement and subsequent pathology.
Other research has suggested that B. trehalosi can inhibit
the growth of M. haemolytica. Dassanayake et al. [15] re-
ported that B. trehalosi inhibited the growth of M. haemo-
lytica in co-culture when B. trehalosi enters the stationary
phase. One possible explanation for this finding is that;
when both bacteria are inoculated simultaneously, B. tre-
halosi may inhibit in vivo growth of M. haemolytica until
the immune system removes B. trehalosi. This postulated
in vivo inhibition may delay the onset of clinical signs of
BRD (such as a temperature spike and decrease the subse-
quent severity of lung involvement.
Our goal was to determine if B. trehalosi is really an
emerging primary BRD pathogen as has been reported
or if infection occurs secondary to some other viral/bac-
terial insult. Cortese et al. [7] have reported peracute
fatal pneumonia in healthy adult cattle attributed to B.
trehalosi. Other, anecdotal reports concerning B. treha-
losi and BRD, suggest that B. trehalosi is associated with
severe fibinous pneumonia with consolidation (especially
caudal lobes) and pleuritis that is unresponsive to anti-
microbial therapy. The more minor role that B. trehalosi
may play in BRD is supported by the isolation results de-
scribed in this study. B. trehalosi was isolated from only
one set of lungs post inoculation and in that case the
sample was obtained only 3 days following inoculation
from a calf that had been inoculated with both B. treha-
losi and M. haemolytica. This finding suggests that B.
trehalosi may not persist long term in bovine lung. The
temperature response of calves inoculated with B. treha-
losi or M. haemolytica was different (p < 0.05) over time.
The early spike and rapid return to normal in rectal
temperature from the B. trehalosi inoculated calves may
indicate that the immune system in the lungs may more
rapidly identify and respond to a B. trehalosi bacterial
insult compared to the M. haemolytica inoculated calves.
The authors acknowledge that B. trehalosi isolates have
been obtained from samples submitted from field cases.
These “positives” suggest the occurrence of an oppor-
tunistic infection and proliferation of B. trehalosi after
normal lung defenses have been compromised by other
primary respiratory pathogens. The plausibility of B. tre-
halosi as a secondary, perhaps even an opportunistic,
pathogen is a stronger argument than B. trehalosi as an
emerging primary BRD pathogen of economic importance.
Conclusion
This pilot study suggests that B. trehalosi may not be an
important primary pathogen of respiratory disease in cat-
tle. The study’s results suggest that B. trehalosi is likely a
secondary, or perhaps opportunistic, BRD pathogen. Cul-
ture of this bacterium from diagnostic submissions should
not necessarily be interpreted cited as a primary cause of
respiratory disease but may still have a role as a secondary
pathogen or an opportunistic invader. Clinicians and diag-
nosticians should temper a B. trehalosi culture in context
of the clinical setting. Practically, identification of B.
trehalosi as the primary isolate from a submitted lung
sample may suggest a failure in identification or treat-
ment of a major BRD pathogen such as M. haemolytica.
Further challenge studies designed to assess B.trehalosi’s
interaction with other BRD pathogens (IBR, BVDV,
Mycoplasma bovis, Histophilus somni) should be con-
ducted. Additionally, a challenge model designed to
evaluate if B. trehalosi, inoculated after M. haemolytica
has already initiated lung damage, can lead to more
severe BRD would be beneficial.
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